Digital Pathology Companies

The digital pathology market is expected to grow from USD 1.46 billion in 2025 to USD 2.75 billion by 2030 with a CAGR of 13.5%. The growth is mainly attributed to the shortage of pathologists globally, the increasing need for remote diagnostic capabilities, and the escalating prevalence of chronic diseases. Artificial intelligence-driven analysis, whole-slide imaging, and sophisticated digital software also enhance diagnostic operations and their precision.

The digital pathology market is competitive and dominated by a few prominent competitors such as  Danaher Corporation (US),  Philips N.V. (Netherlands), Hamamatsu Photonics K.K. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), among others. Key players in digital pathology are focusing on AI integration and strategic partnerships. Companies like Philips and Roche are embedding AI to automate image analysis and improve diagnostic accuracy, while also forming alliances with hospitals and tech firms to expand adoption and co-develop advanced solutions.

To know about the assumptions considered for the study download the pdf brochure

Danaher Corporation (US)

Danaher Corporation has emerged as a digital pathology market leader.   Leica Biosystems, a subsidiary, provides services ranging from biopsy to radiology, pathology, surgery, and cancer diagnosis.   In March 2023, the company partnered with Paige (US) to improve the use of digital pathology workflows in hospitals and laboratories. The cooperation will result in a new diagnostic platform and the co-development of next-generation AI-powered companion diagnostics.

In addition, the company has collaborated with the European Society for Digital and Integrative Pathology (ESDIP) to promote the use of digital pathology throughout Europe. Such initiatives have played a pivotal role in solidifying its leadership in the digital pathology market.

Koninklijke Philips N.V. (Netherlands)

Philips has positioned itself as a market leader in digital pathology by offering solutions that enhance efficiency, cooperation, and diagnostic accuracy. Transitioning from analog to digital workflows enables efficiency gains of 15–20% per case, allowing pathologists to handle more cases in less time. The digitization of workflows supports remote collaboration and faster consensus-building. Philips also addresses the shortage of qualified pathologists by offering tools that streamline workflows and foster multidisciplinary teamwork. Its platform enables real-time consultations and discussions, enhancing patient care. The company has refined its solution based on insights from over 300 customers and 20+ hospital labs.

Market Ranking:

The digital pathology market is highly competitive, with top players accounting for 55–65% of global revenues. Danaher drives growth through aggressive R&D and M&A, integrating its Aperio scanners with AI partnerships and investing in Indica Labs’ modular, API-based platforms. Philips focuses on converging pathology and radiology via its IntelliSite platform, leveraging partnerships with major health systems. Hamamatsu emphasizes high-resolution imaging with NanoZoomer, backed by multi-year distribution deals. In 2023, it partnered with Siemens Healthineers and OEMs, including Agilent, to expand regional reach. The remaining 35–45% of the market includes niche players focused on AI, cloud deployments, and regulatory certification.

Related Reports:

Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com